首页|HBV相关慢加急性肝衰竭前期进展预测模型构建

HBV相关慢加急性肝衰竭前期进展预测模型构建

扫码查看
目的 探讨HBV相关慢加急性肝衰竭前期(HBV-Pre.ACLF)进展的预测指标及预测模型建立.方法 采用回顾性病例分析研究,筛选 2018 年 1 月至 2022 年 6 月我院收治的符合纳入标准的患者 102 例,以进展到ACLF为观察终点,分析患者各项临床指标;通过单因素及多因素分析寻找出HBV-Pre.ACLF进展的独立危险因素及建立预测模型.结果 基线水平时临床指标ALB、血钠及MELD、MELD-Na评分、是否联合前列地尔治疗为HBV-Pre.ACLF进展的独立危险因素(P<0.05);根据二元logistic回归分析结果,构建出HBV-Pre.ACLF进展预测模型得Logit(P)=34.75-0.34*ALB-0.16*血钠-1.26*前列地尔治疗(联合前列地尔治疗为 1,未联合治疗为 0).结论 HBV-Pre.ACLF基线时ALB、血Na、FIB及MELD、MELD-Na评分系统对疾病进展有一定的预测价值,早期联合前列地尔治疗能够在一定程度上遏制HBV-Pre.ACLF进展.
Construction of a Predictive Model for Progression of HBV-related Pre-acute-on-chronic Pre-liver Failure
Objectives To explore the predictive indicators and establishment of a predictive model for the progres-sion of HBV-related Pre-acute-on-chronic Liver Failure(HBV-Pre-ACLF)progression.Methods A retrospective case study was conducted to screen 102 patients who met the inclusion criteria in our hospital from January 2018 to June 2022.The clinical indicators of the patients were analyzed with the progression to ACLF as the observation end point.Through univariate and multivariate analyses,the independent risk factors of HBV-Pre-ACLF progression were found and the predictive model was established.Results At the baseline level,clinical indicators ALB,blood sodium,MELD,and MELD-sodium scores,and whether alprostadil was combined with treatment were independent risk factors for the progression of HBV-Pre-ACLF(P<0.05).According to the results of binary logistic regression analysis,the prediction model Logit(P)=34.75-0.34*ALB-0.16* serum sodium-1.26*alprostadil therapy(1 for combi-nation with alprostadil therapy,0 for non-combination therapy)was established.Conclusions The scoring system of ALB,blood sodium,FIB,MELD and MELD-sodium at the baseline of HBV-Pre-ACLF has certain predictive value for the disease progression,and early treatment combined with alprostadil can curb the progress of HBV-Pre-ACLF to some extent.

Hepatitis B virusPre-acute-on-chronic liver failurePredictive indicatorsModel

炉军

展开 >

南昌市第九医院,江西 南昌 330002

乙型病毒性肝炎 慢加急性肝衰竭前期 预测指标 模型

江西省卫生健康委普通科技计划

202140125

2024

现代诊断与治疗
南昌市医学会 南昌市医学科学研究所

现代诊断与治疗

影响因子:0.736
ISSN:1001-8174
年,卷(期):2024.35(1)
  • 12